Chris Verathamjamras
Overview
Explore the profile of Chris Verathamjamras including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
56
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Verathamjamras C, Chantaraamporn J, Sornprachum T, Mutapat P, Chokchaichamnankit D, Mingkwan K, et al.
Clin Proteomics
. 2023 Apr;
20(1):15.
PMID: 37024778
Background: Colorectal cancer (CRC) is one of the major causes of cancer-related death worldwide. Although commercial biomarkers of CRC are currently available, they are still lacking in terms of sensitivity...
2.
Keeratichamroen S, Lirdprapamongkol K, Thongnest S, Boonsombat J, Chawengrum P, Sornprachum T, et al.
Oncol Rep
. 2021 Nov;
47(1).
PMID: 34738622
Due to drug resistance and disease recurrence, lung cancer remains one of the primary cancer‑related causes of death in both men and women worldwide. In addition, lung cancer is clinically...
3.
Komkleow S, Weeraphan C, Chokchaichamnankit D, Chaisuriya P, Verathamjamras C, Ruangjaroon T, et al.
Anticancer Res
. 2021 Jul;
41(8):3833-3842.
PMID: 34281843
Background/aim: Lung cancer is the leading cause of cancer death worldwide. Cigarette smoke is the most important risk factor for cancer development. Growing evidence indicates that prolonged nicotine exposure is...
4.
Verathamjamras C, Sriwitool T, Netsirisawan P, Chaiyawat P, Chokchaichamnankit D, Prasongsook N, et al.
Glycoconj J
. 2021 Feb;
38(1):55-65.
PMID: 33608772
O-GlcNAcylation, a single attachment of N-acetylglucosamine (GlcNAc) on serine and threonine residues, plays important roles in normal and pathobiological states of many diseases. Aberrant expression of O-GlcNAc modification was found...
5.
Chantaraamporn J, Champattanachai V, Khongmanee A, Verathamjamras C, Prasongsook N, Mingkwan K, et al.
Proteomes
. 2020 Sep;
8(3).
PMID: 32971853
Colorectal cancer (CRC) is a major cause of cancer mortality. Currently used CRC biomarkers provide insufficient sensitivity and specificity; therefore, novel biomarkers are needed to improve the CRC detection. Label-free...
6.
Chokchaichamnankit D, Watcharatanyatip K, Subhasitanont P, Weeraphan C, Keeratichamroen S, Sritana N, et al.
Oncol Lett
. 2019 Jun;
17(6):5453-5468.
PMID: 31186765
Due to the invasive procedure associated with Pap smears for diagnosing cervical cancer and the conservative culture of developing countries, identifying less invasive biomarkers is of great interest. Quantitative label-free...
7.
Weeraphan C, Phongdara A, Chaiyawat P, Diskul-Na-Ayudthaya P, Chokchaichamnankit D, Verathamjamras C, et al.
Proteomics
. 2019 May;
19(12):e1800159.
PMID: 31054213
The northeastern region of Thailand is well known to have a high incidence and mortality of cholangiocarcinoma (CCA). Protein phosphorylation status has been reported to reflect a key determinant of...
8.
Ketudat Cairns J, Champattanachai V, Srisomsap C, Paricharttanakul N, Verathamjamras C, Lirdprapamongkol K, et al.
Biophys Rev
. 2017 Sep;
9(6):857-860.
PMID: 28884448
No abstract available.
9.
Verathamjamras C, Weeraphan C, Chokchaichamnankit D, Watcharatanyatip K, Subhasitanont P, Diskul-Na-Ayudthaya P, et al.
Int J Oncol
. 2017 Jun;
51(1):269-280.
PMID: 28560424
Cholangiocarcinoma (CCA), derived from the bile duct, occurs with a relatively high incidence in Northeast Thailand. Early diagnosis is still hampered by the lack of sufficient biomarkers. In recent years,...
10.
Tian Y, Verathamjamras C, Kawashita N, Okamoto K, Yasunaga T, Ikuta K, et al.
J Mol Model
. 2012 Sep;
19(1):465-75.
PMID: 22949064
Cyclophilin A has attracted attention recently as a new target of anti-human immunodeficiency virus type 1 (HIV-1) drugs. However, so far no drug against HIV-1 infection exhibiting this mechanism of...